Sign In
Home
About Us
Benefits
Pricing
Krixos GmbH
Contact Us
Subscribe now
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Cancer Stat:
Sign Up Now:
Your email:
or call us on: +44 (0)20 7769 6707
or email:
apus@templetonapus.com
Most viewed
1.
Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer
2.
Janux Therapeutics Announces $56 Million Series A to Advance Novel Cancer Drug Candidates Using T Cell Engager (TRACTr) Technology
3.
Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
4.
Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic
5.
Money on the Move: February 24 – March 2
6.
Top 10 Pharm Country Companies to Receive NIH Funding in 2020
7.
Biotheus Completes $100 Million Funding for Biologic Drugs
8.
Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis
9.
Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals
10.
A need for experts in pediatric onco-nephrology
Last updated at 21:08 GMT
Hot News Makers
Health/Pharma Companies
Five Prime Therapeutics
101192.81
Astra Zeneca
82849.96
European Medicines Agency
63516.17
Merck KGaA
47426.22
Check4Cancer
36814.54
CureVac
27905.38
Novartis
24384.91
Olive Tree Ventures
23462.24
eTheRNA
17069.50
BevCanna Enterprises
16044.45
Last updated at 21:10 GMT